Nanomedicines Petition: Ensuring patient safety through regulatory clarity – sign the petition
In collaboration with other European associations, the EAASM has produced a leaflet calling upon DG SANTE, the EMA, Member States’ health authorities and regulatory bodies to address unmet medical needs and enhance quality, safety and efficacy of nanomedicines and nanosimilars by addressing patient safety issues due to significant regulatory challenges across Europe.